格隆汇10月9日丨海正药业(600267.SH)公布,公司产品1,4-丁二磺酸腺苷蛋氨酸,按照美国FDA GRAS准则完成Self-GRAS(Self-affirmed Generallyrecognized as safe)科学评价并获得专家组一致批准,正式通过美国Self-GRAS认证。
切换
首页 > 事件详情
格隆汇10月9日丨海正药业(600267.SH)公布,公司产品1,4-丁二磺酸腺苷蛋氨酸,按照美国FDA GRAS准则完成Self-GRAS(Self-affirmed Generallyrecognized as safe)科学评价并获得专家组一致批准,正式通过美国Self-GRAS认证。